5 Recruiting Pediatric Solid Tumor Phase 1 Clinical Trials

Active phase 1 studies for pediatric solid tumor enrolling across the USA. Verify eligibility and contact site coordinators.

All Pediatric Solid Tumor studies

Phase 1 Studies for Pediatric Solid Tumor

🔵 Active, Not Recruiting Phase1

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

📍 Lucile Packard Children's Hospital — Palo Alto, California

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1

EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

📍 Seattle Children's Hospital — Seattle, Washington

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

📍 Seattle Children's Hospital — Seattle, Washington

View Study & Checklist ➔

🟡 Not Yet Recruiting Phase1

B7-H3.CD28Z.CART in Solid Tumors

📍 Dana Farber Cancer Institite — Boston, Massachusetts

View Study & Checklist ➔

🟢 Recruiting Phase1

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

📍 St. Jude Children's Research Hospital — Memphis, Tennessee

View Study & Checklist ➔